The endocannabinoid system is a neuromodulatory system responsible for partial regulation of cognitive and emotional processes in the human central nervous system such as behavior, mood disorders, and neurologic disorders …
On July 1st, 2021, new cannabis legalization are going into effect in Connecticut, New Mexico, and Virginia, just a couple days after a recreational cannabis legalization measure went into effect …
The most common reasons people get medical marijuana cards: 2021 edition Read More »
Cannabidiol (CBD), the main nonpsychoactive constituent of Cannabis sativa, has shown a wide range of therapeutically promising pharmacological effects either as a sole drug or in combination with other drugs …
There is increasing interest in the use of cannabinoids for disease and symptom management, but limited information available regarding their pharmacokinetics and pharmacodynamics to guide prescribers. Cannabis medicines contain a …
The pharmacokinetics and the pharmacodynamics of cannabinoids Read More »
Cannabis categorization and nomenclature is more complex than you might think — and more important, too. The standard categorization in recent decades, strains, is on its way out. It is …
In order to expand research and advocacy for the use of cannabinoid therapeutics in veterinary practice, the Society of Cannabis Clinicians and allied organizations held an inaugural International Veterinary Cannabis …
Enabling Cannabis Access In Veterinary Medicine: Building International Awareness Read More »
Women who used cannabis during pregnancy could be at an increased risk of a variety of adverse maternal and infant outcomes, in particular preterm birth and small birth size, according …
Cannabis use in pregnancy tied to range of birth problems, study says Read More »
If you’re a peanut butter fan, then there’s really only one George Washington in your book – George Washington Carver. One of America’s most renowned scientists and inventors, Carver created …
This randomized, double-blind, placebo-controlled, cross-over study was conducted to evaluate the safety and efficacy of two-weeks of nightly sublingual cannabinoid extract (ZTL-101) in treating chronic insomnia (symptoms ≥three months). The …
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy Read More »
This randomized, double-blind, placebo-controlled, cross-over study was conducted to evaluate the safety and efficacy of two-weeks of nightly sublingual cannabinoid extract (ZTL-101) in treating chronic insomnia (symptoms ≥three months). The …